256 related articles for article (PubMed ID: 24562574)
1. Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.
Correa RJ; Valdes YR; Peart TM; Fazio EN; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Carcinogenesis; 2014 Sep; 35(9):1951-61. PubMed ID: 24562574
[TBL] [Abstract][Full Text] [Related]
2. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.
Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG
Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204
[TBL] [Abstract][Full Text] [Related]
3. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine reverses chemoresistance via upregulation of p21
Hwang JR; Kim WY; Cho YJ; Ryu JY; Choi JJ; Jeong SY; Kim MS; Kim JH; Paik ES; Lee YY; Han HD; Lee JW
Cell Death Dis; 2020 Dec; 11(12):1034. PubMed ID: 33277461
[TBL] [Abstract][Full Text] [Related]
5. BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.
Peart TM; Correa RJ; Valdes YR; Dimattia GE; Shepherd TG
Clin Exp Metastasis; 2012 Apr; 29(4):293-313. PubMed ID: 22249415
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine or chloroquine-PI3K/Akt pathway inhibitor combinations strongly promote γ-irradiation-induced cell death in primary stem-like glioma cells.
Firat E; Weyerbrock A; Gaedicke S; Grosu AL; Niedermann G
PLoS One; 2012; 7(10):e47357. PubMed ID: 23091617
[TBL] [Abstract][Full Text] [Related]
7. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
[TBL] [Abstract][Full Text] [Related]
8. Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo.
Zhang Q; Yang M; Qu Z; Zhou J; Jiang Q
Biochem Biophys Res Commun; 2016 Nov; 480(3):334-340. PubMed ID: 27756618
[TBL] [Abstract][Full Text] [Related]
9. Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM.
Yang Z; Liu Y; Wei X; Zhou X; Gong C; Zhang T; Jin P; Xu S; Ma D; Gao Q
Curr Cancer Drug Targets; 2015; 15(3):215-26. PubMed ID: 25619386
[TBL] [Abstract][Full Text] [Related]
10. Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents.
Degtyarev M; De Mazière A; Orr C; Lin J; Lee BB; Tien JY; Prior WW; van Dijk S; Wu H; Gray DC; Davis DP; Stern HM; Murray LJ; Hoeflich KP; Klumperman J; Friedman LS; Lin K
J Cell Biol; 2008 Oct; 183(1):101-16. PubMed ID: 18838554
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of Autophagy by Chloroquine Alone or in Combination with mTOR Inhibitors Induces Apoptosis in Neuroendocrine Tumor Cells.
Avniel-Polak S; Leibowitz G; Riahi Y; Glaser B; Gross DJ; Grozinsky-Glasberg S
Neuroendocrinology; 2016; 103(6):724-37. PubMed ID: 26619207
[TBL] [Abstract][Full Text] [Related]
12. Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia.
Shao S; Li S; Qin Y; Wang X; Yang Y; Bai H; Zhou L; Zhao C; Wang C
Int J Oncol; 2014 May; 44(5):1661-8. PubMed ID: 24585095
[TBL] [Abstract][Full Text] [Related]
13. Blockade of autophagy enhances proapoptotic potential of BI-69A11, a novel Akt inhibitor, in colon carcinoma.
Pal I; Parida S; Prashanth Kumar BN; Banik P; Kumar Dey K; Chakraborty S; Bhutia SK; Mandal M
Eur J Pharmacol; 2015 Oct; 765():217-27. PubMed ID: 26306675
[TBL] [Abstract][Full Text] [Related]
14. Effect of PI3K/Akt pathway inhibition-mediated G1 arrest on chemosensitization in ovarian cancer cells.
Fekete M; Santiskulvong C; Eng C; Dorigo O
Anticancer Res; 2012 Feb; 32(2):445-52. PubMed ID: 22287731
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair.
Ovejero-Sánchez M; González-Sarmiento R; Herrero AB
Neoplasia; 2021 May; 23(5):515-528. PubMed ID: 33930758
[TBL] [Abstract][Full Text] [Related]
16. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids.
Ziske MA; Pettee KM; Khaing M; Rubinic K; Eisenmann KM
Biochem Biophys Res Commun; 2016 Mar; 472(1):33-9. PubMed ID: 26898799
[TBL] [Abstract][Full Text] [Related]
17. MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.
Whicker ME; Lin ZP; Hanna R; Sartorelli AC; Ratner ES
BMC Cancer; 2016 Jul; 16():550. PubMed ID: 27465688
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells.
Goncharenko-Khaider N; Lane D; Matte I; Rancourt C; Piché A
Oncogene; 2010 Oct; 29(40):5523-36. PubMed ID: 20661217
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models.
Cocco S; Leone A; Roca MS; Lombardi R; Piezzo M; Caputo R; Ciardiello C; Costantini S; Bruzzese F; Sisalli MJ; Budillon A; De Laurentiis M
J Transl Med; 2022 Jun; 20(1):290. PubMed ID: 35761360
[TBL] [Abstract][Full Text] [Related]
20. The anti-tumourigenic effect of ellagic acid in SKOV-3 ovarian cancer cells entails activation of autophagy mediated by inhibiting Akt and activating AMPK.
Elsaid FG; Alshehri MA; Shati AA; Al-Kahtani MA; Alsheri AS; Massoud EE; El-Kott AF; El-Mekkawy HI; Al-Ramlawy AM; Abdraboh ME
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1611-1621. PubMed ID: 32415699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]